Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Van Andel Research Institute
Cortice Biosciences, Inc.
Information provided by (Responsible Party):
Giselle Sholler, Spectrum Health Hospitals
ClinicalTrials.gov Identifier:
NCT01483820
First received: November 28, 2011
Last updated: November 17, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2018
  Estimated Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)